다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

BC43

Inter-amer 30 (BC43)

Inter-amer 30

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:LSE:BC43

일자	시간	출처	헤드라인	심볼	기업
2002/11/13	23:09	UK Regulatory	Rebecca O. Kendall Announces Retirement; Robert A. Armitage Promoted to Lilly Senior Vice President, General Counsel	LSE:BC43	Inter-amer 30
2002/11/09	18:30	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
2002/11/08	21:30	UK Regulatory	Lilly Outlines to Wall Street Its Strategy To Realize Its Growth Opportunities and Deliver Superior Earnings Growth Over the Lon	LSE:BC43	Inter-amer 30
2002/11/08	16:19	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
2002/11/08	03:08	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
2002/11/06	01:02	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
2002/11/01	22:47	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
2002/10/31	00:03	UK Regulatory	Eli Lilly and Company	LSE:BC43	Inter-amer 30
2002/10/29	23:00	UK Regulatory	Cymbalta Data Suggest Rapid and Sustained Response by First Week of Therapy	LSE:BC43	Inter-amer 30
2002/10/23	21:10	UK Regulatory	3rd Quarter Results	LSE:BC43	Inter-amer 30
2002/10/22	16:01	UK Regulatory	Alimta Continues To Show Versatility in Treating Different Cancers	LSE:BC43	Inter-amer 30
2002/10/22	05:15	UK Regulatory	Dividend Declaration	LSE:BC43	Inter-amer 30
2002/10/18	16:00	UK Regulatory	Combining Innovative Therapies for Optimal Cancer Care; Effectiveness of Gemzar-Based Combination Regimens is Topic of Workshop	LSE:BC43	Inter-amer 30
2002/10/01	23:10	UK Regulatory	Newly Published Study Demonstrates Sustained Efficacy of Evista -raloxifene HCl- in Reducing Risk of Spinal Fractures	LSE:BC43	Inter-amer 30
2002/09/26	06:59	UK Regulatory	Lilly Asserts The New England Journal of Medicine ``Sounding Board'' Opinion Article Attempts to Turn Back the Clock on Care of	LSE:BC43	Inter-amer 30
2002/09/25	06:39	UK Regulatory	Re Alliance	LSE:BC43	Inter-amer 30
2002/09/24	09:05	UK Regulatory	Re Alliance	LSE:BC43	Inter-amer 30
2002/09/20	22:07	UK Regulatory	Statement re	LSE:BC43	Inter-amer 30
2002/09/17	23:34	UK Regulatory	Lilly Launches World's Largest Severe Sepsis Clinical Trial; 11,000 Patients to be Enrolled in Study of Xigris Use in Patients w	LSE:BC43	Inter-amer 30
2002/09/17	02:02	UK Regulatory	FDA Issues Approvable Letter for Lilly's Cymbalta for Treatment of Depression; From the Makers of Prozac, Cymbalta Will Offer Ne	LSE:BC43	Inter-amer 30
2002/09/16	23:04	UK Regulatory	Miscellaneous	LSE:BC43	Inter-amer 30
2002/09/03	23:08	UK Regulatory	Tadalafil for the Treatment of Erectile Dysfunction Receives Positive Recommendation From the Australian Drug Evaluation Committ	LSE:BC43	Inter-amer 30
2002/08/27	04:11	UK Regulatory	Regulatory Approval	LSE:BC43	Inter-amer 30
2002/08/27	00:44	UK Regulatory	Miscellaneous	LSE:BC43	Inter-amer 30
2002/08/15	04:02	UK Regulatory	Miscellaneous	LSE:BC43	Inter-amer 30
2002/08/15	01:56	UK Regulatory	Miscellaneous	LSE:BC43	Inter-amer 30
2002/08/14	22:29	UK Regulatory	FDA Issues Approvable Letter for Strattera for ADHD; Strattera Would Give Patients, Families and Physicians a New Treatment Opti	LSE:BC43	Inter-amer 30
2002/08/01	16:23	UK Regulatory	Lilly's Xigris Becomes First and Only Medical Product Approved for BIPA Payment in Medicare Patients	LSE:BC43	Inter-amer 30
2002/07/30	23:50	UK Regulatory	Re Alliance	LSE:BC43	Inter-amer 30
2002/07/26	05:03	UK Regulatory	Lilly ICOS LLC	LSE:BC43	Inter-amer 30

검색 관련기사 보기:LSE:BC43

Vontobel Financial Produ...

Hunter Creek Mining (CE)

Investec Bnk 26

Societe Generale Effekten

Klondike Silver

Fin.res.ser1a3a

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관